CLEAN EARTH ACQUISITION-RGHT (CLINR) Stock Fundamental Analysis

NASDAQ:CLINR • US1844931204

0.144 USD
+0 (+3.08%)
At close: Dec 22, 2023
0.29 USD
+0.15 (+101.39%)
After Hours: 12/22/2023, 8:20:54 PM
Overview Stock Chart Technical Analysis News
Fundamental Rating

2

Overall CLINR gets a fundamental rating of 2 out of 10. We evaluated CLINR against 0 industry peers in the Unkown industry. While CLINR seems to be doing ok healthwise, there are quite some concerns on its profitability. CLINR does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year CLINR was profitable.
  • CLINR had a positive operating cash flow in the past year.
CLINR Yearly Net Income VS EBIT VS OCF VS FCFCLINR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 0 -500K -1M

1.2 Ratios

Industry RankSector Rank
ROA 4.82%
ROE 5.11%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CLINR Yearly ROA, ROE, ROICCLINR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 0 -0.1 -0.2 -0.3 -0.4

1.3 Margins

  • CLINR does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CLINR Yearly Profit, Operating, Gross MarginsCLINR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • Compared to 1 year ago, CLINR has more shares outstanding
  • CLINR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CLINR Yearly Shares OutstandingCLINR Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 10M 20M 30M
CLINR Yearly Total Debt VS Total AssetsCLINR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 50M 100M 150M 200M

2.2 Solvency

  • CLINR has an Altman-Z score of 1.26. This is a bad value and indicates that CLINR is not financially healthy and even has some risk of bankruptcy.
  • CLINR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 1.26
ROIC/WACCN/A
WACCN/A
CLINR Yearly LT Debt VS Equity VS FCFCLINR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 0 50M 100M 150M 200M

2.3 Liquidity

  • CLINR has a Current Ratio of 17.61. This indicates that CLINR is financially healthy and has no problem in meeting its short term obligations.
  • A Quick Ratio of 17.61 indicates that CLINR has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 17.61
Quick Ratio 17.61
CLINR Yearly Current Assets VS Current LiabilitesCLINR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 50M 100M 150M 200M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. Growth

3.1 Past

EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocksShow best growing peers

2

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 1.03, the valuation of CLINR can be described as very cheap.
  • When comparing the Price/Earnings ratio of CLINR to the average of the S&P500 Index (26.99), we can say CLINR is valued rather cheaply.
Industry RankSector Rank
PE 1.03
Fwd PE N/A
CLINR Price Earnings VS Forward Price EarningsCLINR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 0.88
EV/EBITDA N/A
CLINR Per share dataCLINR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4 5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • CLINR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

CLEAN EARTH ACQUISITION-RGHT

NASDAQ:CLINR (12/22/2023, 8:20:54 PM)

After market: 0.29 +0.15 (+101.39%)

0.144

+0 (+3.08%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners12.74%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap2.02M
Revenue(TTM)N/A
Net Income(TTM)4.16M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 1.03
Fwd PE N/A
P/S N/A
P/FCF 0.88
P/OCF 0.88
P/B 0.02
P/tB 0.02
EV/EBITDA N/A
EPS(TTM)0.14
EY97.22%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.16
FCFY113.6%
OCF(TTM)0.16
OCFY113.6%
SpS0
BVpS5.79
TBVpS5.79
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 4.82%
ROE 5.11%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 55.29%
Current Ratio 17.61
Quick Ratio 17.61
Altman-Z 1.26
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

CLEAN EARTH ACQUISITION-RGHT / CLINR FAQ

Can you provide the ChartMill fundamental rating for CLEAN EARTH ACQUISITION-RGHT?

ChartMill assigns a fundamental rating of 2 / 10 to CLINR.


What is the valuation status for CLINR stock?

ChartMill assigns a valuation rating of 2 / 10 to CLEAN EARTH ACQUISITION-RGHT (CLINR). This can be considered as Overvalued.


How profitable is CLEAN EARTH ACQUISITION-RGHT (CLINR) stock?

CLEAN EARTH ACQUISITION-RGHT (CLINR) has a profitability rating of 1 / 10.


What is the financial health of CLEAN EARTH ACQUISITION-RGHT (CLINR) stock?

The financial health rating of CLEAN EARTH ACQUISITION-RGHT (CLINR) is 5 / 10.